Consun Pharmaceutical Group Limited (1681.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Consun Pharmaceutical Group Limited, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 11.06x |
| P/B Ratio | 2.65x |
| P/S Ratio | 3.52x |
| Profitability | |
| Gross Margin | 78.0% |
| Operating Margin | 35.2% |
| Net Margin | 31.5% |
| EBITDA Margin | 35.3% |
| Liquidity | |
| Current Ratio | 3.22x |
| Quick Ratio | 3.03x |
| Leverage | |
| Debt/Equity | 0.05x |
YoY = year-over-year change. Source: FMP..